Home » Analyst Articles – US

Piper Sandler Analysts Decrease Earnings Estimates for Antares Pharma, Inc. (NASDAQ:ATRS)

Piper Sandler Analysts Decrease Earnings Estimates for Antares Pharma, Inc. (NASDAQ:ATRS)

Antares Pharma, Inc. (NASDAQ:ATRS) – Equities research analysts at Piper Sandler dropped their Q1 2021 earnings estimates for shares of Antares Pharma in a report issued on Tuesday, March 2nd. Piper Sandler analyst D. Amsellem... 
FY2021 EPS Estimates for Lumber Liquidators Holdings, Inc. (NYSE:LL) Increased by Wedbush

FY2021 EPS Estimates for Lumber Liquidators Holdings, Inc. (NYSE:LL) Increased by Wedbush

Lumber Liquidators Holdings, Inc. (NYSE:LL) – Analysts at Wedbush upped their FY2021 EPS estimates for Lumber Liquidators in a research report issued on Wednesday, March 3rd. Wedbush analyst S. Basham now forecasts that the... 
Wedbush Comments on The Gap, Inc.’s FY2021 Earnings (NYSE:GPS)

Wedbush Comments on The Gap, Inc.’s FY2021 Earnings (NYSE:GPS)

The Gap, Inc. (NYSE:GPS) – Wedbush reduced their FY2021 earnings per share estimates for The Gap in a note issued to investors on Monday, March 1st. Wedbush analyst J. Redding now anticipates that the apparel retailer will... 
FY2021 EPS Estimates for Hanger, Inc. (NYSE:HNGR) Reduced by Analyst

FY2021 EPS Estimates for Hanger, Inc. (NYSE:HNGR) Reduced by Analyst

Hanger, Inc. (NYSE:HNGR) – Equities research analysts at Jefferies Financial Group dropped their FY2021 EPS estimates for shares of Hanger in a report issued on Monday, March 1st. Jefferies Financial Group analyst B. Tanquilut... 
FY2021 Earnings Estimate for Novavax, Inc. (NASDAQ:NVAX) Issued By Cantor Fitzgerald

FY2021 Earnings Estimate for Novavax, Inc. (NASDAQ:NVAX) Issued By Cantor Fitzgerald

Novavax, Inc. (NASDAQ:NVAX) – Equities researchers at Cantor Fitzgerald decreased their FY2021 earnings per share (EPS) estimates for Novavax in a report released on Tuesday, March 2nd. Cantor Fitzgerald analyst C. Duncan... 
Q1 2021 EPS Estimates for ChemoCentryx, Inc. Decreased by Analyst (NASDAQ:CCXI)

Q1 2021 EPS Estimates for ChemoCentryx, Inc. Decreased by Analyst (NASDAQ:CCXI)

ChemoCentryx, Inc. (NASDAQ:CCXI) – Investment analysts at Piper Sandler decreased their Q1 2021 earnings per share (EPS) estimates for ChemoCentryx in a research note issued to investors on Monday, March 1st. Piper Sandler... 
FY2021 Earnings Forecast for Suzuki Motor Co. (OTCMKTS:SZKMY) Issued By Jefferies Financial Group

FY2021 Earnings Forecast for Suzuki Motor Co. (OTCMKTS:SZKMY) Issued By Jefferies Financial Group

Suzuki Motor Co. (OTCMKTS:SZKMY) – Analysts at Jefferies Financial Group increased their FY2021 EPS estimates for Suzuki Motor in a research note issued to investors on Tuesday, March 2nd. Jefferies Financial Group analyst... 
Research Analysts Issue Forecasts for Cargojet Inc. (CJT.TO)’s FY2021 Earnings (TSE:CJT)

Research Analysts Issue Forecasts for Cargojet Inc. (CJT.TO)’s FY2021 Earnings (TSE:CJT)

Cargojet Inc. (CJT.TO) (TSE:CJT) – Beacon Securities dropped their FY2021 earnings per share (EPS) estimates for shares of Cargojet Inc. (CJT.TO) in a note issued to investors on Monday, March 1st. Beacon Securities analyst... 
Translate Bio, Inc. (NASDAQ:TBIO) to Post FY2021 Earnings of ($1.05) Per Share, Jefferies Financial Group Forecasts

Translate Bio, Inc. (NASDAQ:TBIO) to Post FY2021 Earnings of ($1.05) Per Share, Jefferies Financial Group Forecasts

Translate Bio, Inc. (NASDAQ:TBIO) – Investment analysts at Jefferies Financial Group lowered their FY2021 earnings per share estimates for Translate Bio in a research report issued to clients and investors on Monday, March... 
FY2021 EPS Estimates for Turning Point Therapeutics, Inc. Lowered by SVB Leerink (NASDAQ:TPTX)

FY2021 EPS Estimates for Turning Point Therapeutics, Inc. Lowered by SVB Leerink (NASDAQ:TPTX)

Turning Point Therapeutics, Inc. (NASDAQ:TPTX) – Equities research analysts at SVB Leerink lowered their FY2021 EPS estimates for shares of Turning Point Therapeutics in a research report issued to clients and investors on... 
Intellia Therapeutics (NASDAQ:NTLA) Research Coverage Started at JMP Securities

Intellia Therapeutics (NASDAQ:NTLA) Research Coverage Started at JMP Securities

Analysts at JMP Securities assumed coverage on shares of Intellia Therapeutics (NASDAQ:NTLA) in a research report issued to clients and investors on Thursday, The Fly reports. The firm set an “outperform” rating on the... 
Honda Motor Co., Ltd. Forecasted to Post Q1 2022 Earnings of $0.98 Per Share (NYSE:HMC)

Honda Motor Co., Ltd. Forecasted to Post Q1 2022 Earnings of $0.98 Per Share (NYSE:HMC)

Honda Motor Co., Ltd. (NYSE:HMC) – Investment analysts at Jefferies Financial Group issued their Q1 2022 earnings per share (EPS) estimates for shares of Honda Motor in a research report issued to clients and investors on... 
Mizuho Downgrades STORE Capital (NYSE:STOR) to Equal Weight

Mizuho Downgrades STORE Capital (NYSE:STOR) to Equal Weight

STORE Capital (NYSE:STOR) was downgraded by analysts at Mizuho from a “buy” rating to an “equal weight” rating in a research note issued to investors on Thursday, The Fly reports. They currently have a $33.00... 
Ovid Therapeutics (NASDAQ:OVID) Price Target Increased to $5.00 by Analysts at UBS Group

Ovid Therapeutics (NASDAQ:OVID) Price Target Increased to $5.00 by Analysts at UBS Group

Ovid Therapeutics (NASDAQ:OVID) had its price objective increased by equities research analysts at UBS Group from $4.00 to $5.00 in a research note issued to investors on Thursday, The Fly reports. The firm currently has a “neutral”... 
Mizuho Downgrades VEREIT (NYSE:VER) to Equal Weight

Mizuho Downgrades VEREIT (NYSE:VER) to Equal Weight

VEREIT (NYSE:VER) was downgraded by investment analysts at Mizuho from a “buy” rating to an “equal weight” rating in a research report issued to clients and investors on Thursday, The Fly reports. They currently... 
Splunk (NASDAQ:SPLK) PT Lowered to $206.00

Splunk (NASDAQ:SPLK) PT Lowered to $206.00

Splunk (NASDAQ:SPLK) had its target price cut by Barclays from $220.00 to $206.00 in a research report issued to clients and investors on Thursday, The Fly reports. The firm presently has an “overweight” rating on the... 
LogicBio Therapeutics (NASDAQ:LOGC) Now Covered by Analysts at JMP Securities

LogicBio Therapeutics (NASDAQ:LOGC) Now Covered by Analysts at JMP Securities

Investment analysts at JMP Securities started coverage on shares of LogicBio Therapeutics (NASDAQ:LOGC) in a report released on Thursday, The Fly reports. The firm set an “outperform” rating on the stock. A number of other... 
J.B. Hunt Transport Services (NASDAQ:JBHT) Lifted to “Buy” at Bank of America

J.B. Hunt Transport Services (NASDAQ:JBHT) Lifted to “Buy” at Bank of America

J.B. Hunt Transport Services (NASDAQ:JBHT) was upgraded by research analysts at Bank of America from a “neutral” rating to a “buy” rating in a research note issued to investors on Thursday, The Fly reports. JBHT... 
Werner Enterprises (NASDAQ:WERN) Upgraded to “Buy” by Bank of America

Werner Enterprises (NASDAQ:WERN) Upgraded to “Buy” by Bank of America

Werner Enterprises (NASDAQ:WERN) was upgraded by research analysts at Bank of America from a “neutral” rating to a “buy” rating in a report released on Thursday, The Fly reports. Several other analysts also... 
Astec Industries, Inc. Expected to Post Q2 2021 Earnings of $0.76 Per Share (NASDAQ:ASTE)

Astec Industries, Inc. Expected to Post Q2 2021 Earnings of $0.76 Per Share (NASDAQ:ASTE)

Astec Industries, Inc. (NASDAQ:ASTE) – Equities research analysts at William Blair issued their Q2 2021 earnings per share estimates for Astec Industries in a research report issued to clients and investors on Tuesday, March... 
Boenning Scattergood Lowers WSFS Financial (NASDAQ:WSFS) to Neutral

Boenning Scattergood Lowers WSFS Financial (NASDAQ:WSFS) to Neutral

WSFS Financial (NASDAQ:WSFS) was downgraded by equities research analysts at Boenning Scattergood from an “outperform” rating to a “neutral” rating in a report released on Thursday, The Fly reports. WSFS has... 
Splunk (NASDAQ:SPLK) PT Lowered to $200.00 at Robert W. Baird

Splunk (NASDAQ:SPLK) PT Lowered to $200.00 at Robert W. Baird

Splunk (NASDAQ:SPLK) had its price objective decreased by investment analysts at Robert W. Baird from $215.00 to $200.00 in a research report issued to clients and investors on Thursday, The Fly reports. The firm currently has an... 
AGCO (NYSE:AGCO) Price Target Increased to $145.00 by Analysts at Deutsche Bank Aktiengesellschaft

AGCO (NYSE:AGCO) Price Target Increased to $145.00 by Analysts at Deutsche Bank Aktiengesellschaft

AGCO (NYSE:AGCO) had its target price boosted by equities research analysts at Deutsche Bank Aktiengesellschaft from $141.00 to $145.00 in a research note issued on Thursday, The Fly reports. The firm presently has a “buy”... 
Domo (NASDAQ:DOMO) Price Target Raised to $80.00 at JMP Securities

Domo (NASDAQ:DOMO) Price Target Raised to $80.00 at JMP Securities

Domo (NASDAQ:DOMO) had its price objective lifted by equities researchers at JMP Securities from $60.00 to $80.00 in a research note issued to investors on Thursday, The Fly reports. The brokerage presently has an “outperform”... 
Barclays Boosts The Descartes Systems Group (NASDAQ:DSGX) Price Target to $63.00

Barclays Boosts The Descartes Systems Group (NASDAQ:DSGX) Price Target to $63.00

The Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) had its price objective lifted by research analysts at Barclays from $59.00 to $63.00 in a report released on Thursday, The Fly reports. The brokerage currently has an “equal...